2025-07-23 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the data you provided. The report is in English with a focus on key figures and concise analysis.

## UnitedHealth Group Inc (UNH) Analysis

**Ticker:** UNH
**Company Name:** UnitedHealth Group Inc
**Company Overview:** UnitedHealth Group is a diversified health care company providing a wide range of products and services, such as health insurance, pharmacy benefit management, and healthcare delivery.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** 13.09%
*   **VOO Cumulative Return:** 97.07%
*   **Relative Divergence:**
    *   Max: 55.3
    *   Min: -85.2
    *   Current: -85.2
    *   Relative Divergence (Current Position): 0.0

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) over the period examined. The current relative divergence is at the lowest end of its historical range, indicating substantial underperformance compared to the benchmark.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD   | Alpha   | Beta | Cap(B) |
|------------|---------|-------|---------|------|--------|
| 2015-2017  | 65.0%   | 56.6% | 36.0%   | 0.0  | 200.0  |
| 2016-2018  | 52.0%   | 63.7% | 34.0%   | 0.0  | 226.0  |
| 2017-2019  | 38.0%   | 63.7% | 9.0%    | 0.3  | 266.7  |
| 2018-2020  | -21.0%  | 63.7% | -40.0%  | 0.4  | 318.1  |
| 2019-2021  | 36.0%   | 61.0% | -13.0%  | 0.4  | 455.5  |
| 2020-2022  | 28.0%   | 66.9% | 26.0%   | 0.4  | 480.9  |
| 2021-2023  | 33.0%   | 67.5% | 15.0%   | 0.4  | 477.6  |
| 2022-2024  | -31.0%  | 68.6% | -57.0%  | 0.3  | 458.9  |
| 2023-2025  | -63.0%  | 75.7% | -112.0% | 0.2  | 258.6  |

**Analysis of Alpha, Beta Table:**

*   **CAGR:** Shows a decline in recent periods, with significant negative growth in the 2022-2025 period.
*   **MDD:** Maximum Drawdown is consistently high, indicating substantial risk and volatility.
*   **Alpha:** Alpha has turned significantly negative in recent periods, indicating UNH is underperforming relative to its risk-adjusted benchmark.
*   **Beta:** Beta remains relatively low, suggesting lower sensitivity to market movements (S&P 500).
*   **Cap:** Market capitalization has fluctuated.

### 2. Recent Price Action

*   **Current Price:** 285.13
*   **Previous Close:** 282.14
*   **Change:** 1.06
*   **5-Day Moving Average:** 286.096
*   **20-Day Moving Average:** 300.4527
*   **60-Day Moving Average:** 321.6198

**Analysis:** The stock price is currently below its 5-day, 20-day, and 60-day moving averages, indicating a downtrend. The recent price increase is relatively small, suggesting limited positive momentum.

### 3. Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 16.16 (Oversold)
*   **PPO:** -0.368
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-Day) Relative Divergence Change:** -0.6 (Negative - Short-Term Decline)
*   **Expected Return:** 1139.6% (Long-Term, vs. S&P 500)

**Analysis:**

*   **MRI:** Suggests low overall market risk.
*   **RSI:** The low RSI indicates the stock is heavily oversold and may be due for a rebound.
*   **PPO:** A negative PPO indicates the short-term moving average is below the long-term moving average, confirming the downtrend.
*   **Hybrid Signal:** The hybrid signal recommends a cautious buy, indicating some potential upside while acknowledging the existing risks.
*   **Recent Price Change Reflection:** The price change of 1.06, while positive, isn't large enough to suggest a major reversal or volatility spike on its own. If it were a significantly larger change, it would warrant noting a potential rapid shift in momentum.
*   **Expected Return:** The extremely high expected return suggests substantial long-term potential compared to the S&P 500, but this should be viewed with skepticism and further investigation given the recent underperformance.

### 4. Recent News & Significant Events

*   **[2025-07-20]** Major business developments, regulatory changes, or market events.
*   **[2025-07-19]** Analysts discussing performance and outlook based on industry trends and economic factors.
*   **[2025-07-21]** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-07-23]** Market experts highlighting risks and opportunities, advising monitoring of news and announcements.

**Analysis:** Recent news points to volatility and significant developments impacting UNH. Monitoring upcoming announcements and analyst opinions is crucial for informed decision-making.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출          |
|------------|-------|---------------|
| 2025-05-07 | 6.9   | 109.58 B$    |
| 2024-11-04 | 6.56  | 100.82 B$    |
| 2024-08-09 | 4.58  | 98.86 B$    |
| 2024-05-09 | -1.53 | 99.80 B$    |
| 2025-05-07 | -1.53 | 99.80 B$    |

**Analysis:**
*   The company had negative EPS during the first half of 2024, followed by a strong positive EPS in the last two quarters.
*   Revenue has been steadily increasing, indicating growth in the company's operations.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | $109.58B  | 21.70%        |
| 2024-12-31 | $100.81B  | 21.14%        |
| 2024-09-30 | $100.82B  | 22.84%        |
| 2024-06-30 | $98.86B  | 22.31%        |
| 2024-03-31 | $99.80B  | 23.05%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE    |
|------------|------------|--------|
| 2025-03-31 | $95.04B  | 6.62%  |
| 2024-12-31 | $92.66B  | 5.98%  |
| 2024-09-30 | $94.53B  | 6.41%  |
| 2024-06-30 | $89.36B  | 4.72%  |
| 2024-03-31 | $86.69B  | -1.63% |

**Analysis:**

*   **Revenue:** Revenue shows a general upward trend, reflecting sales growth.
*   **Profit Margin:** Profit margins are relatively stable, indicating consistent profitability.
*   **Equity:** Equity has increased over the quarters, suggesting a stronger financial position.
*   **ROE:** ROE shows improvement after a negative value, indicating better profitability relative to equity.

### 7. Overall Analysis & Summary

UNH has significantly underperformed the S&P 500 recently. While the stock is currently oversold based on RSI, and the MRI indicates low market risk, the downtrend is evident in the moving averages and PPO. Recent news suggests potential volatility and important developments to monitor. Revenue and equity have generally trended upward, but earnings have been uneven with a negative EPS earlier in 2024. The excessively high expected return should be viewed cautiously, requiring further scrutiny. The hybrid signal suggests a cautious buy. Overall, UNH presents a mixed picture with potential for a rebound but significant risks.

**Recommendation:** Investors should proceed with caution, closely monitoring news, analyst ratings, and further financial data before making investment decisions. A more in-depth analysis of the company's specific challenges and opportunities within the healthcare sector is warranted.
